Reuters have reported that the AZ vaccine is actually quite effective against P1 in Brazil (as are all the others):
https://www.thepharmaletter.com/article/vaccines-seem-effective-against-brazilian-variant
Whatever the reason for the vaccine escape of the South African variant, it doesn't appear to be duplicated in Brazil. We do also now know that a stronger immune response takes place if the doses of the AZ vaccine are spaced out to 12 weeks. The trials in South Africa had the doses given with a 4 week spacing so you'd hope for slightly better numbers if this was increased to 12 weeks.
What we really need to know is how much the vaccines protect against severe illness against that variant. Theoretically, it ought to be a good amount, but the numbers are lacking at present.
I do wonder, when the 'boosters' become available, if we'll see a deliberate attempt to give a different vector to the original vaccinations. This would make sense, if the organisational ability is there.
A sidenote to the SA data...the 40% that got positive...had MUCH milder symptoms and MUCH less need for hospitalization.
The devil is in the details